CD8A and neoplasm: To further determine whether the therapeutic antitumor effect of CT was dependent on the generation of antitumor immunity in this tumor model, mice bearing Hepa1-6 tumors were treated with CT plus anti-PD-L1 without or with depleting antibody against mouse CD4, CD8, or NK cells.